Markku Korpela

Summary

Affiliation: Tampere University Hospital
Country: Finland

Publications

  1. ncbi request reprint Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study
    Markku Korpela
    Tampere University Hospital, Tampere, Finland
    Arthritis Rheum 50:2072-81. 2004
  2. pmc Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial
    Vappu Rantalaiho
    Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital, PO Box 2000, FI 33521 Tampere, Finland
    Arthritis Res Ther 12:R122. 2010
  3. ncbi request reprint Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritis
    Vappu Rantalaiho
    Tampere University Hospital, Tampere, Finland
    Clin Exp Rheumatol 30:S27-31. 2012
  4. doi request reprint The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial
    Vappu Rantalaiho
    Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital, Tampere, Finland
    Arthritis Rheum 60:1222-31. 2009
  5. doi request reprint Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000-8
    Vappu Marianna Rantalaiho
    Tampere University Hospital, PO Box 2000, FI 33521 Tampere, Finland
    Ann Rheum Dis 72:672-7. 2013
  6. doi request reprint Do the 2010 ACR/EULAR or ACR 1987 classification criteria predict erosive disease in early arthritis?
    Heidi Makinen
    Department of Rheumatology, Tampere University Hospital, PL 2000, 33521 Tampere, Finland
    Ann Rheum Dis 72:745-7. 2013
  7. doi request reprint Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological center: two years' drug survival
    Tiina Levälampi
    The Immunopharmacology Research Group, Medical School, University of Tampere and Research Unit, Tampere University Hospital, 33014, Tampere, Finland
    Rheumatol Int 30:1611-20. 2010
  8. ncbi request reprint Etanercept and adalimumab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons leading to discontinuation of the treatment
    Tiina Levälampi
    The Immunopharmacology Research Group, Medical School, University of Tampere and Research Unit, Tampere University Hospital, Tampere, Finland
    Rheumatol Int 28:261-9. 2008
  9. ncbi request reprint Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study
    Susanna Sihvonen
    Department of Internal Medicine and Research Unit, Tampere University Hospital, Medical School, and School of Public Health, University of Tampere, Tampere, Finland
    J Rheumatol 33:1740-6. 2006
  10. doi request reprint Joint symptoms after a large waterborne gastroenteritis outbreak--a controlled, population-based questionnaire study
    Janne Laine
    Department of Internal Medicine, Tampere University Hospital, Finland
    Rheumatology (Oxford) 51:513-8. 2012

Detail Information

Publications10

  1. ncbi request reprint Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study
    Markku Korpela
    Tampere University Hospital, Tampere, Finland
    Arthritis Rheum 50:2072-81. 2004
    ....
  2. pmc Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial
    Vappu Rantalaiho
    Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital, PO Box 2000, FI 33521 Tampere, Finland
    Arthritis Res Ther 12:R122. 2010
    ..The aim of this study was to evaluate the radiologic progression beyond that time in patients with early RA initially treated with a combination of three disease-modifying antirheumatic drugs (DMARDs) or a single DMARD...
  3. ncbi request reprint Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritis
    Vappu Rantalaiho
    Tampere University Hospital, Tampere, Finland
    Clin Exp Rheumatol 30:S27-31. 2012
    ..As a consequence, the use of biologics in early RA is less frequent in Finland compared to many countries. Simultaneously, however, at least one hard outcome of RA, work disability, has decreased...
  4. doi request reprint The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial
    Vappu Rantalaiho
    Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital, Tampere, Finland
    Arthritis Rheum 60:1222-31. 2009
    ..To evaluate the evolution of functional and clinical outcomes over 11 years in patients with early rheumatoid arthritis (RA) initially treated with a combination of 3 disease-modifying antirheumatic drugs (DMARDs) or with a single DMARD...
  5. doi request reprint Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000-8
    Vappu Marianna Rantalaiho
    Tampere University Hospital, PO Box 2000, FI 33521 Tampere, Finland
    Ann Rheum Dis 72:672-7. 2013
    ..To study whether the work disability (WD) rates in early rheumatoid arthritis (RA) have changed in Finland, where the treatment of RA has long been active but has intensified further since 2000...
  6. doi request reprint Do the 2010 ACR/EULAR or ACR 1987 classification criteria predict erosive disease in early arthritis?
    Heidi Makinen
    Department of Rheumatology, Tampere University Hospital, PL 2000, 33521 Tampere, Finland
    Ann Rheum Dis 72:745-7. 2013
    ..The new 2010 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria for rheumatoid arthritis (RA) aim at earlier diagnosis of RA compared to the 1987 ACR criteria...
  7. doi request reprint Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological center: two years' drug survival
    Tiina Levälampi
    The Immunopharmacology Research Group, Medical School, University of Tampere and Research Unit, Tampere University Hospital, 33014, Tampere, Finland
    Rheumatol Int 30:1611-20. 2010
    ..The drug survival with infliximab was 40% after 2 years of follow-up. During the 2-year follow-up, 60% discontinued infliximab treatment, mainly due to unsatisfactory or waning efficacy or a severe adverse event...
  8. ncbi request reprint Etanercept and adalimumab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons leading to discontinuation of the treatment
    Tiina Levälampi
    The Immunopharmacology Research Group, Medical School, University of Tampere and Research Unit, Tampere University Hospital, Tampere, Finland
    Rheumatol Int 28:261-9. 2008
    ..Adverse events (mainly infections and injection reactions) were in line with previous reports. Three rare adverse events were reported: one patient with ovarial carcinoma, one with leukopenia and one with features of drug-induced SLE...
  9. ncbi request reprint Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study
    Susanna Sihvonen
    Department of Internal Medicine and Research Unit, Tampere University Hospital, Medical School, and School of Public Health, University of Tampere, Tampere, Finland
    J Rheumatol 33:1740-6. 2006
    ..To evaluate mortality and causes of death in patients with rheumatoid arthritis (RA) treated with low-dose oral glucocorticoids...
  10. doi request reprint Joint symptoms after a large waterborne gastroenteritis outbreak--a controlled, population-based questionnaire study
    Janne Laine
    Department of Internal Medicine, Tampere University Hospital, Finland
    Rheumatology (Oxford) 51:513-8. 2012
    ..In November 2007, a gastroenteritis outbreak due to faecal contamination of tap water took place in a Finnish town. The purpose of this study was to evaluate the occurrence of joint symptoms after the outbreak...